Anixa Biosciences, Inc. (ANIX)
2.95
+0.18
(+6.50%)
USD |
NASDAQ |
Oct 02, 16:00
2.94
-0.01
(-0.34%)
After-Hours: 20:00
Anixa Biosciences EPS Diluted (Quarterly) : -0.0762 for July 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.0762 |
| April 30, 2026 | -0.0749 |
| January 31, 2026 | -0.0772 |
| October 31, 2025 | -0.0816 |
| July 31, 2025 | -0.0695 |
| April 30, 2025 | -0.0866 |
| January 31, 2025 | -0.0989 |
| October 31, 2024 | -0.0896 |
| July 31, 2024 | -0.1022 |
| April 30, 2024 | -0.0984 |
| January 31, 2024 | -0.1035 |
| October 31, 2023 | -0.0865 |
| July 31, 2023 | -0.0811 |
| April 30, 2023 | -0.074 |
| January 31, 2023 | -0.0751 |
| October 31, 2022 | -0.113 |
| July 31, 2022 | -0.0902 |
| April 30, 2022 | -0.1175 |
| January 31, 2022 | -0.1271 |
| October 31, 2021 | -0.1336 |
| July 31, 2021 | -0.1423 |
| April 30, 2021 | -0.0837 |
| January 31, 2021 | -0.0878 |
| October 31, 2020 | -0.0917 |
| July 31, 2020 | -0.1106 |
| Date | Value |
|---|---|
| April 30, 2020 | -0.1248 |
| January 31, 2020 | -0.1252 |
| October 31, 2019 | -0.1027 |
| July 31, 2019 | -0.1065 |
| April 30, 2019 | -0.1292 |
| January 31, 2019 | -0.2546 |
| October 31, 2018 | -0.2804 |
| July 31, 2018 | -0.30 |
| April 30, 2018 | -0.08 |
| January 31, 2018 | -0.11 |
| October 31, 2017 | -0.11 |
| July 31, 2017 | -0.12 |
| April 30, 2017 | 0.02 |
| January 31, 2017 | -0.41 |
| October 31, 2016 | -0.12 |
| July 31, 2016 | -0.13 |
| April 30, 2016 | -0.15 |
| January 31, 2016 | -0.18 |
| October 31, 2015 | -0.1481 |
| July 31, 2015 | -0.18 |
| April 30, 2015 | -0.25 |
| January 31, 2015 | 0.50 |
| October 31, 2014 | -0.3588 |
| July 31, 2014 | 0.046 |
| April 30, 2014 | -0.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Vicapsys Life Sciences, Inc. | -0.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.625M |
| Total Expenses (Quarterly) | 2.606M |
| Enterprise Value | 87.06M |
| Earnings Yield | -10.51% |
| Normalized Earnings Yield | -10.51 |